Lucid Diagnostics, Inc. (LUCD)
0.819
-0.08
(-8.68%)
USD |
NASDAQ |
Sep 09, 16:00
0.819
0.00 (0.00%)
After-Hours: 17:07
Lucid Diagnostics Enterprise Value : 162.58M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 162.58M |
| September 04, 2026 | 170.72M |
| September 03, 2026 | 172.95M |
| September 02, 2026 | 180.34M |
| September 01, 2026 | 177.32M |
| August 31, 2026 | 178.18M |
| August 28, 2026 | 180.62M |
| August 27, 2026 | 179.21M |
| August 26, 2026 | 176.67M |
| August 25, 2026 | 184.17M |
| August 24, 2026 | 182.26M |
| August 21, 2026 | 175.45M |
| August 20, 2026 | 174.71M |
| August 19, 2026 | 184.17M |
| August 18, 2026 | 180.26M |
| August 17, 2026 | 178.01M |
| August 14, 2026 | 176.10M |
| August 13, 2026 | 175.57M |
| August 12, 2026 | 179.29M |
| August 11, 2026 | 174.88M |
| August 10, 2026 | 174.84M |
| August 07, 2026 | 175.99M |
| August 06, 2026 | 173.32M |
| August 05, 2026 | 182.26M |
| August 04, 2026 | 174.48M |
| Date | Value |
|---|---|
| August 03, 2026 | 176.23M |
| July 31, 2026 | 157.77M |
| July 30, 2026 | 163.42M |
| July 29, 2026 | 166.73M |
| July 28, 2026 | 165.93M |
| July 27, 2026 | 163.84M |
| July 24, 2026 | 164.64M |
| July 23, 2026 | 171.87M |
| July 22, 2026 | 171.77M |
| July 21, 2026 | 175.91M |
| July 20, 2026 | 176.41M |
| July 17, 2026 | 172.76M |
| July 16, 2026 | 185.12M |
| July 15, 2026 | 210.88M |
| July 14, 2026 | 182.26M |
| July 13, 2026 | 180.56M |
| July 10, 2026 | 182.26M |
| July 09, 2026 | 180.39M |
| July 08, 2026 | 176.12M |
| July 07, 2026 | 187.98M |
| July 06, 2026 | 197.52M |
| July 02, 2026 | 195.62M |
| July 01, 2026 | 191.80M |
| June 30, 2026 | 195.62M |
| June 29, 2026 | 182.18M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PAVmed, Inc. | 30.98M |
| Alphatec Holdings, Inc. | 1.912B |
| Electromed, Inc. | 209.84M |
| Pulse Biosciences, Inc. | 3.359B |
| Abbott Laboratories | 210.25B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.69M |
| Revenue (Quarterly) | 1.474M |
| Total Expenses (Quarterly) | 13.16M |
| EPS Diluted (Quarterly) | -0.0804 |
| Gross Profit Margin (Quarterly) | -13.23% |
| Profit Margin (Quarterly) | -792.9% |
| Earnings Yield | -57.29% |
| Normalized Earnings Yield | -56.10 |